DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,677,000 | -5.5% | 333,241 | -8.6% | 0.37% | +4.5% |
| Q2 2023 | $87,531,000 | -8.4% | 364,713 | -3.9% | 0.35% | -11.3% |
| Q1 2023 | $95,608,000 | -7.8% | 379,336 | -2.9% | 0.40% | -11.6% |
| Q4 2022 | $103,683,000 | +3.9% | 390,638 | +1.1% | 0.45% | 0.0% |
| Q3 2022 | $99,827,000 | +2.7% | 386,490 | +0.8% | 0.45% | +9.0% |
| Q2 2022 | $97,217,000 | -14.8% | 383,470 | -1.5% | 0.41% | +2.5% |
| Q1 2022 | $114,148,000 | -13.8% | 389,147 | -3.3% | 0.40% | -9.2% |
| Q4 2021 | $132,358,000 | +4.8% | 402,292 | -3.0% | 0.44% | -1.1% |
| Q3 2021 | $126,311,000 | +13.2% | 414,897 | -0.2% | 0.45% | +14.0% |
| Q2 2021 | $111,599,000 | +19.5% | 415,854 | +0.3% | 0.39% | +6.2% |
| Q1 2021 | $93,350,000 | +8.0% | 414,742 | +6.6% | 0.37% | -4.4% |
| Q4 2020 | $86,415,000 | +11.2% | 389,012 | +7.8% | 0.39% | -8.7% |
| Q3 2020 | $77,708,000 | +23.7% | 360,877 | +1.6% | 0.42% | +18.4% |
| Q2 2020 | $62,835,000 | +28.5% | 355,344 | +0.6% | 0.36% | +6.5% |
| Q1 2020 | $48,883,000 | -16.4% | 353,173 | -7.3% | 0.34% | +11.2% |
| Q4 2019 | $58,484,000 | -2.7% | 381,055 | -8.5% | 0.30% | -5.6% |
| Q3 2019 | $60,136,000 | +1.5% | 416,370 | +0.5% | 0.32% | +0.9% |
| Q2 2019 | $59,224,000 | -2.8% | 414,383 | -10.2% | 0.32% | -0.3% |
| Q1 2019 | $60,920,000 | +34.7% | 461,445 | +5.2% | 0.32% | +21.3% |
| Q4 2018 | $45,227,000 | -4.4% | 438,586 | +0.8% | 0.26% | +12.9% |
| Q3 2018 | $47,292,000 | +11.0% | 435,228 | +0.8% | 0.23% | +7.9% |
| Q2 2018 | $42,614,000 | +6.1% | 431,844 | +5.2% | 0.22% | +2.9% |
| Q1 2018 | $40,176,000 | +1.1% | 410,340 | -4.2% | 0.21% | +8.2% |
| Q4 2017 | $39,743,000 | +9.5% | 428,171 | +1.2% | 0.19% | +3.2% |
| Q3 2017 | $36,286,000 | -49.0% | 423,011 | -49.8% | 0.19% | -3.6% |
| Q2 2017 | $71,118,000 | +102.7% | 842,738 | +105.4% | 0.20% | -1.0% |
| Q1 2017 | $35,086,000 | +0.9% | 410,215 | 0.0% | 0.20% | +1.0% |
| Q4 2016 | $34,786,000 | +4.6% | 410,215 | -3.3% | 0.20% | -4.4% |
| Q3 2016 | $33,270,000 | -23.3% | 424,421 | -1.2% | 0.20% | -27.1% |
| Q2 2016 | $43,392,000 | +8.4% | 429,621 | +1.8% | 0.28% | +6.5% |
| Q1 2016 | $40,044,000 | -20.5% | 422,142 | -22.2% | 0.26% | -14.9% |
| Q4 2015 | $50,371,000 | +31.9% | 542,328 | +21.0% | 0.31% | +27.7% |
| Q3 2015 | $38,182,000 | -0.7% | 448,095 | -0.2% | 0.24% | +9.5% |
| Q2 2015 | $38,439,000 | +2.3% | 449,103 | +1.5% | 0.22% | +2.8% |
| Q1 2015 | $37,557,000 | -0.7% | 442,370 | +0.3% | 0.22% | -2.3% |
| Q4 2014 | $37,806,000 | +12.7% | 441,093 | -0.1% | 0.22% | +11.1% |
| Q3 2014 | $33,536,000 | -12.3% | 441,373 | -9.2% | 0.20% | -7.9% |
| Q2 2014 | $38,252,000 | +4.6% | 485,869 | -0.4% | 0.22% | +0.9% |
| Q1 2014 | $36,587,000 | -12.4% | 487,827 | -9.9% | 0.21% | -4.9% |
| Q4 2013 | $41,784,000 | +11.6% | 541,249 | +0.2% | 0.22% | +11.4% |
| Q3 2013 | $37,430,000 | +6.4% | 539,959 | -2.9% | 0.20% | +1.0% |
| Q2 2013 | $35,187,000 | – | 555,871 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |